Details
Manufacturer:
-Les Laboratoires Servier Industrie, France
Registration Number :
-MAL09062164ARZ
Content
-
Formulation: Each tablet contains 7.5 mg of ivabradine as the hydrochloride salt.
-
Appearance: Salmon-coloured, triangular, film-coated tablet engraved with “7.5” on one face and the Servier logo on the other.
-
Inactive Ingredients: Lactose monohydrate, magnesium stearate, maize starch, maltodextrin, colloidal anhydrous silica, hypromellose, titanium dioxide (E171), macrogol 6000, glycerol, yellow iron oxide (E172), red iron oxide (E172).
Indications
Coralan 7.5mg is indicated for:
-
Chronic Stable Angina Pectoris: Symptomatic treatment in adults with normal sinus rhythm and heart rate ≥70 bpm, who are unable to tolerate or have contraindications to β-blockers, or in combination with β-blockers in patients inadequately controlled with optimal β-blocker dose.
-
Chronic Heart Failure: In patients with NYHA class II to IV, systolic dysfunction, sinus rhythm, and heart rate ≥75 bpm, in combination with standard therapy including β-blocker therapy, or when β-blocker therapy is contraindicated or not tolerated.
Instructions
-
Administration: Take orally twice daily during meals.
-
Dosage:
-
Chronic Stable Angina Pectoris: Start with 5 mg twice daily. After 3–4 weeks, if heart rate remains above 60 bpm and the initial dose is well tolerated, increase to 7.5 mg twice daily.
-
Chronic Heart Failure: Start with 5 mg twice daily. After 2 weeks, if resting heart rate is persistently above 60 bpm, increase to 7.5 mg twice daily.
-
-
Precautions: Monitor heart rate regularly. If heart rate decreases below 50 bpm or symptoms of bradycardia occur, reduce dose to 2.5 mg twice daily.
-
Storage: Store below 30°C, in the original package to protect from moisture. Keep out of reach of children.
View more about Coralan 7.5mg on main site